Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (321-330 of 441) with videos related to

Pageof 45
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancersGiampaolo Bianchini, Yuan Qi, Ricardo H Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entityAndrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Breast cancer molecular subtypes respond differently to preoperative chemotherapyRoman Rouzier, Charles M Perou, W Fraser Symmans, et al.
Breast Cancer Research and Treatment|December 15, 2010
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancerTakayuki Iwamoto, Giampaolo Bianchini, Yuan Qi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancerStacy L Moulder, W Fraser Symmans, Daniel J Booser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerMassimo Cristofanilli, Daniel F Hayes, G Thomas Budd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapyAna M Gonzalez-Angulo, Sean E McGuire, Thomas A Buchholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast CancerGiovanna Rossi, Zhaomei Mu, Alfred W Rademaker, et al.
Thrombosis and Haemostasis|November 7, 2014
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancerMichal Mego, Zhuang Zuo, Hui Gao, et al.
The Oncologist|June 28, 2017
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 ResultsSibylle Loibl, Nicholas C Turner, Jungsil Ro, et al.
Pageof 45

Showing results (321-330 of 441) with videos related to

Sort By:
Pageof 45
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancersGiampaolo Bianchini, Yuan Qi, Ricardo H Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
Molecular characterization of patients with metastatic invasive lobular carcinoma (ILC): using real-world data to describe this unique clinical entityAndrew A Davis, Ellen Jaeger, Ian S Hagemann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Breast cancer molecular subtypes respond differently to preoperative chemotherapyRoman Rouzier, Charles M Perou, W Fraser Symmans, et al.
Breast Cancer Research and Treatment|December 15, 2010
Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancerTakayuki Iwamoto, Giampaolo Bianchini, Yuan Qi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancerStacy L Moulder, W Fraser Symmans, Daniel J Booser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerMassimo Cristofanilli, Daniel F Hayes, G Thomas Budd, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapyAna M Gonzalez-Angulo, Sean E McGuire, Thomas A Buchholz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2017
Cell-Free DNA and Circulating Tumor Cells: Comprehensive Liquid Biopsy Analysis in Advanced Breast CancerGiovanna Rossi, Zhaomei Mu, Alfred W Rademaker, et al.
Thrombosis and Haemostasis|November 7, 2014
Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancerMichal Mego, Zhuang Zuo, Hui Gao, et al.
The Oncologist|June 28, 2017
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 ResultsSibylle Loibl, Nicholas C Turner, Jungsil Ro, et al.
Pageof 45